HealthScholar Rock wins first FDA approval for rare muscle-wasting disease

The U.S. Food and Drug Administration approved Scholar Rock’s therapy on Friday for a rare genetic condition that causes muscle weakness, giving the company its first regulatory approval.

Scholar RockFDA approvalmuscle wastingrare genetic disease

RReuters★★★☆☆2026-09-11 23:50Original